Receptors, Cholecystokinin, antagonists & inhibitors
- Name
- Receptors, Cholecystokinin, antagonists & inhibitors
- Accession Number
- DBCAT002817
- Description
Not Available
- Drugs
Drug Drug Description Netazepide Netazepide has been used in trials studying the prevention and treatment of Dyspepsia, Hypergastrinaemia, Barrett's Esophagus, ECL-cell Hyperplasia, and Rebound Hyperacidity, among others. - Drugs & Drug Targets
Drug Target Type